查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1561570

2024-2032 年按產品、應用、最終用戶和地區分類的羊膜市場報告

Amniotic Membrane Market Report by Product, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2023年，全球IMARC Group市場規模達15億美元。對微創（MI）治療的日益青睞、糖尿病和類風濕關節炎等多種慢性疾病的盛行率上升，以及專科診所和醫院的擴張是推動市場的一些主要因素。

羊膜是胎盤的最內層，由厚的基底膜和無血管基質組成。它是一種源自胎盤的生物組織，由於其獨特的特性而用於醫療應用。它透過調節炎症反應來減少炎症，並最大限度地減少組織中的纖維化和疤痕。它可以舒緩疼痛的傷口和燒傷，並縮短其癒合時間。它安全且耐受性良好，排斥率低，廣泛用於角膜潰瘍等眼表疾病的手術。它還用作生物敷料，以減少粘連並促進恢復。

人們對微創 (MI) 治療的日益青睞導致羊膜在各種外科手術中的利用率不斷提高。此外，醫療基礎設施的成長以及專科診所和醫院的擴張為羊膜療法的實施提供了更多機會。除此之外，各種領先的市場參與者都專注於併購（M&A），以擴大其影響力、分享專業知識並進入新市場。此外，公司正在積極使其產品線多樣化，提供適合各種手術和治療需求的羊膜。此外，一些國家的政府正在加強對醫療保健專業人員和患者進行有關羊膜的好處和應用的教育，這提供了良好的市場前景。

羊膜市場趨勢/促進因素：

對再生醫學的需求不斷增加

糖尿病和類風濕性關節炎等幾種慢性疾病的盛行率不斷上升，導致慢性傷口和潰瘍，增加了對有效治療方法的需求。羊膜提供了一種創新的解決方案並刺激癒合過程。除此之外，全球老年人口不斷成長，極易受到各種健康狀況的影響，這推動了對促進更快癒合和組織再生的治療的需求。此外，骨科和牙科等各種醫學專業擴大採用羊膜，這對市場產生了積極影響。此外，羊膜促進細胞生長和減少發炎的能力正在推動其在其他再生治療中的採用。

醫療程序的技術進步

先進技術的整合正在導致羊膜的開發提高效率和功效。現代技術確保維持必需的生長因子和癒合特性，從而增強其在各個醫學領域的適用性。羊膜與幹細胞療法和3D（3D）生物列印等尖端治療方法的兼容性提供了良好的市場前景。這些整合可以實現更個人化和有效的治療，並提高患者護理的品質。除此之外，改進的保存方法允許更長的保存期限和更廣泛的分銷，這正在增加其在各個地區和醫療保健系統中的採用。

支持性監管環境

各國監管機構正在認知到羊膜的治療價值，並針對羊膜的提取、加工、保存和應用實施明確且明確的指南。這些準則確保實踐的一致性並維護產品的品質。除此之外，監管機構正在積極監控市場，以確保遵守所有相關規則和標準。定期檢查、審計和報告要求有助於維護行業的信任和誠信。此外，他們還提供支持性政策，包括贈款、激勵措施和鼓勵該領域研究和開發的公私夥伴關係。與研究機構的合作可以推動創新並將新穎的產品和療法推向市場。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球羊膜市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 冷凍保存羊膜
    • 市場趨勢
    • 市場預測
  • 凍乾羊膜
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：按應用

  • 手術傷口
    • 市場趨勢
    • 市場預測
  • 眼科
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院
    • 市場趨勢
    • 市場預測
  • 門診手術中心
    • 市場趨勢
    • 市場預測
  • 專科診所
    • 市場趨勢
    • 市場預測
  • 研究中心和實驗室
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Amnio Technology LLC
    • Amniox Medical Inc. (TissueTech Inc.)
    • Genesis Biologics
    • Human Regenerative Technologies LLC
    • Integra LifeSciences Holdings Corporation
    • Katena Products Inc.
    • MiMedx Group
    • Next Biosciences
    • Skye Biologics Holdings LLC
    • Smith & Nephew plc
    • Surgenex LLC
    • Ventris Medical LLC
    • Wright Medical Group NV (Stryker BV)
Product Code: SR112024A4503

The global amniotic membrane market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2032, exhibiting a growth rate (CAGR) of 8% during 2024-2032. The increasing preference for minimally invasive (MI) treatments, rising prevalence of several chronic conditions like diabetes and rheumatoid arthritis, and the expansion of specialized clinics and hospitals are some of the major factors propelling the market.

The amniotic membrane is the innermost layer of the placenta, which consists of a thick basement membrane and an avascular stromal matrix. It is a biological tissue derived from the placenta and utilized in medical applications due to its unique properties. It reduces inflammation by modulating inflammatory responses and minimizes fibrosis and scarring in tissues. It provides a soothing effect on painful wounds and burns and reduces their healing times. It is safe and well-tolerated, with low rejection rates and widely used in surgeries for ocular surface disorders, such as corneal ulcers. It is also employed as a biological dressing to reduce adhesions and enhance recovery.

The increasing preference for minimally invasive (MI) treatments is resulting in the increasing utilization of the amniotic membrane in various surgical procedures. Additionally, growth in healthcare infrastructure and the expansion of specialized clinics and hospitals are offering more opportunities for the implementation of amniotic membrane therapies. Apart from this, various leading market players are focusing on mergers and acquisitions (M&A) to expand their reach, share expertise, and access new markets. Furthermore, companies are actively diversifying their product lines, offering amniotic membranes tailored for various surgical and therapeutic needs. Moreover, governments of several countries are increasing their efforts to educate healthcare professionals and patients about the benefits and applications of amniotic membranes, which is offering a favorable market outlook.

Amniotic Membrane Market Trends/Drivers:

Increasing demand for regenerative medicine

The rising prevalence of several chronic conditions like diabetes and rheumatoid arthritis, leading to chronic wounds and ulcers is increasing the need for effective treatment methods. Amniotic membranes offer an innovative solution and stimulate the healing process. Apart from this, the growing global geriatric population, which is highly susceptible to various health conditions is driving the need for treatments that promote faster healing and tissue regeneration. Furthermore, the increasing adoption of amniotic membranes in various medical specialties like orthopedics and dental medicine is positively influencing the market. Moreover, the ability of the amniotic membrane to facilitate cellular growth and decrease inflammation is driving its adoption in other regenerative treatments.

Technological advancements in medical procedures

The integration of advanced technologies is resulting in the development of amniotic membranes with increased efficiency and efficacy. Modern techniques ensure that essential growth factors and healing properties are maintained, enhancing their applicability in various medical domains. The compatibility of the amniotic membrane with cutting-edge treatments, such as stem cell therapies and three-dimensional (3D) bioprinting, is offering a favorable market outlook. These integrations allow for more personalized and effective treatments and enhance the quality of patient care. Apart from this, improved preservation methods allow for longer shelf life and wider distribution, which is increasing its adoption across various regions and healthcare systems.

Supportive regulatory environment

Regulatory bodies of various countries are recognizing the therapeutic value of the amniotic membrane and implementing clear and well-defined guidelines for the extraction, processing, preservation, and application of amniotic membranes. These guidelines ensure uniformity in practices and uphold the quality of products. Apart from this, regulatory authorities are actively monitoring the market to ensure compliance with all relevant rules and standards. Regular inspections, audits, and reporting requirements help maintain trust and integrity in the industry. Furthermore, they are offering supportive policies, which include grants, incentives, and public-private partnerships that encourage research and development in the field. Collaborative efforts with research institutions can drive innovation and bring novel products and therapies to market.

Amniotic Membrane Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global amniotic membrane market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, application and end user.

Breakup by Product:

  • Cryopreserved Amniotic Membrane
  • Lyophilization Amniotic Membrane

Cryopreserved amniotic membrane dominates the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes cryopreserved amniotic membrane and lyophilization amniotic membrane. According to the report, cryopreserved amniotic membrane represented the largest segment.

It has a long shelf life and it allows hospitals and clinics to maintain an inventory without the risk of degradation. It also offers ease of storage, simplifies logistics, and reduces waste. Additionally, it aids in maintaining the biological integrity of the amniotic membrane and enhancing the therapeutic effectiveness of the membrane. This ability to retain the natural healing properties is attracting healthcare providers. Apart from this, regulatory bodies are recognizing the benefits of cryopreservation and are actively providing supportive guidelines and approvals. This support from regulatory authorities is promoting the adoption of cryopreserved amniotic membranes across different regions.

Breakup by Application:

  • Surgical Wounds
  • Ophthalmology
  • Others

Surgical wounds account for the majority of the market share

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes surgical wounds, ophthalmology, and others. According to the report, surgical wounds hold the majority of the market share. Increasing road accidents and major sports injuries are leading to a rise in elective and emergency surgeries across various medical disciplines, which is catalyzing the need for effective wound care. Additionally, technological advancements in surgical procedures are allowing for more complex and numerous surgeries to be performed with optimal efficiency. Apart from this, the rising focus on minimizing post-operative infections and complications is driving the demand for high-quality wound care products. The growing awareness about the importance of infection prevention and control is encouraging healthcare providers and patients to opt for optimal wound care solutions. Furthermore, rising preferences for effective healing without significant scarring is leading to innovations in wound care products specifically designed for surgical wounds.

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics
  • Research Centers and Laboratory

Hospitals hold the largest share of the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, ambulatory surgical centers, specialized clinics, and research centers and laboratory. According to the report, hospitals accounted for the largest market share. They have specialized medical professionals and skilled staff trained to deal with various medical conditions. They can offer enhanced diagnostic and therapeutic procedures as they are equipped with technologically advanced medical equipment. Apart from this, they provide emergency medical services and handle urgent and life-threatening situations, which is offering a favorable market outlook. Furthermore, many hospitals have established relationships with insurance providers, facilitating easier and more comprehensive coverage for patients, which makes hospital-based care more accessible for many individuals. Moreover, hospitals in various regions receive government funding and support, which ensures the availability of essential healthcare services to the wider population.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest amniotic membrane market share

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others); Latin America (Brazil, Mexico, and Others); and the Middle East and Africa. According to the report, North America accounted for the largest market share since the region is home to leading research institutions and biotechnology companies that actively invest in the research and development (R&D) activities of regenerative medicine, including amniotic membranes. Additionally, the region has a highly developed healthcare system with state-of-the-art facilities and technology, which drives innovation and facilitates the adoption of advanced medical products, such as amniotic membranes. Apart from this, supportive regulatory guidelines for the development, approval, and use of amniotic membrane products in North America is encouraging manufacturers to expand their market reach. Furthermore, collaborations between hospitals, research institutions, and biotechnology companies is enhancing innovation and market penetration in the region.

Competitive Landscape:

Companies are currently engaging in a variety of activities to expand the scope and efficiency of this unique biological material. They are extracting the amniotic membrane from the placenta and are processing it under carefully controlled conditions. Additionally, they are conducting rigorous R&D, exploring new possibilities for amniotic membrane use in regenerative medicine. Apart from this, they are working continuously to enhance the potential of the amniotic membrane, improving the prospects of new therapies, and continuing to support the broader goals of healthcare and patient well-being. Furthermore, many companies are actively involved in educating healthcare providers about the benefits and applications of the amniotic membrane.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Amnio Technology LLC
  • Amniox Medical Inc. (TissueTech Inc.)
  • Genesis Biologics
  • Human Regenerative Technologies LLC
  • Integra LifeSciences Holdings Corporation
  • Katena Products Inc.
  • MiMedx Group
  • Next Biosciences
  • Skye Biologics Holdings LLC
  • Smith & Nephew plc
  • Surgenex LLC
  • Ventris Medical LLC
  • Wright Medical Group N.V. (Stryker B.V.).

Recent Developments:

  • In February 2022, Amnio Technology LLC launched two new PalinGen membrane products, PalinGen Dual-Layer Membrane and Dual Layer PalinGen X-Membrane. They are minimally manipulated, homologous use and chorion-free.
  • In June 2021, MiMedx Group received reimbursement approval in Japan, making it the first and only amniotic tissue product approved for use in the country.

Key Questions Answered in This Report

  • 1. What was the size of the global amniotic membrane market in 2023?
  • 2. What is the expected growth rate of the global amniotic membrane market during 2024-2032?
  • 3. What are the key factors driving the global amniotic membrane market?
  • 4. What has been the impact of COVID-19 on the global amniotic membrane market?
  • 5. What is the breakup of the global amniotic membrane market based on the product?
  • 6. What is the breakup of the global amniotic membrane market based on the application?
  • 7. What is the breakup of the global amniotic membrane market based on the end user?
  • 8. What are the key regions in the global amniotic membrane market?
  • 9. Who are the key players/companies in the global amniotic membrane market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Amniotic Membrane Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Cryopreserved Amniotic Membrane
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Lyophilization Amniotic Membrane
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Surgical Wounds
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Ophthalmology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Specialized Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Research Centers and Laboratory
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Amnio Technology LLC
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Amniox Medical Inc. (TissueTech Inc.)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Genesis Biologics
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Human Regenerative Technologies LLC
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Integra LifeSciences Holdings Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Katena Products Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 MiMedx Group
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Next Biosciences
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Skye Biologics Holdings LLC
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Smith & Nephew plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Surgenex LLC
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Ventris Medical LLC
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Wright Medical Group N.V. (Stryker B.V.)
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 SWOT Analysis

List of Figures

  • Figure 1: Global: Amniotic Membrane Market: Major Drivers and Challenges
  • Figure 2: Global: Amniotic Membrane Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Amniotic Membrane Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Amniotic Membrane Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Amniotic Membrane Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Amniotic Membrane Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Amniotic Membrane Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Amniotic Membrane (Cryopreserved Amniotic Membrane) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Amniotic Membrane (Cryopreserved Amniotic Membrane) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Amniotic Membrane (Lyophilization Amniotic Membrane) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Amniotic Membrane (Lyophilization Amniotic Membrane) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Amniotic Membrane (Surgical Wounds) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Amniotic Membrane (Surgical Wounds) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Amniotic Membrane (Ophthalmology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Amniotic Membrane (Ophthalmology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Amniotic Membrane (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Amniotic Membrane (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Amniotic Membrane (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Amniotic Membrane (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Amniotic Membrane (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Amniotic Membrane (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Amniotic Membrane (Specialized Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Amniotic Membrane (Specialized Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Amniotic Membrane (Research Centers and Laboratory) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Amniotic Membrane (Research Centers and Laboratory) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: North America: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: North America: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: United States: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: United States: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Canada: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Canada: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Asia-Pacific: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Asia-Pacific: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: China: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: China: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Japan: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Japan: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: India: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: India: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: South Korea: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: South Korea: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Australia: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Australia: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Indonesia: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Indonesia: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Others: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Others: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Europe: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Europe: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Germany: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Germany: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: France: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: France: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: United Kingdom: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: United Kingdom: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Italy: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Italy: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Spain: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Spain: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Russia: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Russia: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Latin America: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Latin America: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Brazil: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Brazil: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Mexico: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Mexico: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Middle East and Africa: Amniotic Membrane Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Middle East and Africa: Amniotic Membrane Market: Breakup by Country (in %), 2023
  • Figure 74: Middle East and Africa: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Global: Amniotic Membrane Industry: SWOT Analysis
  • Figure 76: Global: Amniotic Membrane Industry: Value Chain Analysis
  • Figure 77: Global: Amniotic Membrane Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Amniotic Membrane Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Amniotic Membrane Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Amniotic Membrane Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Amniotic Membrane Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Amniotic Membrane Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Amniotic Membrane Market: Competitive Structure
  • Table 7: Global: Amniotic Membrane Market: Key Players